S Shankar Selected Research

S Shankar Research Topics

Disease

3	Neoplasms (Cancer) 03/2024 - 02/2000
2	Breast Neoplasms (Breast Cancer) 03/2024 - 02/2000
2	Insulin Resistance 01/2021 - 11/2011
2	Myasthenia Gravis 12/2006 - 11/2005
1	COVID-19 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Hyperglycemia 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2020
1	Osteolysis 05/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Burns 06/2017
1	Hematologic Neoplasms (Hematological Malignancy) 07/2016
1	Lymphoma (Lymphomas) 07/2016
1	Infections 04/2015
1	Drug Hypersensitivity Syndrome 07/2013
1	Exanthema (Rash) 07/2013
1	Hypersensitivity (Allergy) 07/2013
1	Eosinophilia 07/2013
1	Ovarian Epithelial Carcinoma 08/2012
1	Glucose Intolerance 11/2011
1	Wounds and Injuries (Trauma) 03/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2010
1	Gangrene 12/2009
1	Pulmonary Hypertension 12/2009
1	Infarction (Infarctions) 12/2009
1	Systemic Scleroderma (Systemic Sclerosis) 12/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2009
1	Subacute Sclerosing Panencephalitis (SSPE) 02/2008
1	Measles 02/2008
1	Heart Diseases (Heart Disease) 12/2006
1	Rheumatoid Arthritis 12/2006
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 11/2006
1	Ankylosing Spondylitis 05/2006
1	Necrosis 10/2004
1	Malaria 10/2001
1	Neuroblastoma 09/2001

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 03/2024 - 02/2008
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2011
1	Messenger RNA (mRNA)IBA 03/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Formaldehyde (Formol)FDA Link 03/2024
1	ParaffinIBA 03/2024
1	human ERBB2 proteinIBA 03/2024
1	Calcium Carbonate (Limestone)FDA Link 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2021
1	AntioxidantsIBA 01/2021
1	ferulic acid (sodium ferulate)IBA 01/2021
1	basal insulin peglisproIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Gentamicins (Gentamicin)FDA LinkGeneric 04/2015
1	Amikacin (A.M.K)FDA LinkGeneric 04/2015
1	Cefotaxime (Kendrick)FDA LinkGeneric 04/2015
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2015
1	Monobactams (Monobactam Antibiotics)IBA 04/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2013
1	abacavir (Ziagen)FDA Link 07/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 07/2013
1	Terbinafine (Lamisil)FDA LinkGeneric 07/2013
1	Allopurinol (Remid)FDA LinkGeneric 07/2013
1	Nevirapine (Viramune)FDA Link 07/2013
1	Minocycline (Cyclops)FDA LinkGeneric 07/2013
1	SulfonamidesIBA 07/2013
1	SteroidsIBA 07/2013
1	Phenytoin (Dilantin)FDA LinkGeneric 07/2013
1	Dapsone FDA Link 07/2013
1	Azathioprine (Imuran)FDA LinkGeneric 07/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2013
1	Cyclin D1IBA 04/2013
1	Caspase 3 (Caspase-3)IBA 04/2013
1	Prednisone (Sone)FDA LinkGeneric 11/2011
1	GlucocorticoidsIBA 11/2011
1	Glucose (Dextrose)FDA LinkGeneric 11/2011
1	Insulin (Novolin)FDA Link 11/2011
1	anti-dsDNA autoantibodyIBA 04/2010
1	DNA (Deoxyribonucleic Acid)IBA 04/2010
1	Antiphospholipid AntibodiesIBA 12/2009
1	Imatinib Mesylate (Gleevec)FDA Link 10/2009
1	Anti-Citrullinated Protein AntibodiesIBA 12/2006
1	cyclic citrullinated peptideIBA 12/2006
1	AntibodiesIBA 12/2006
1	Biomarkers (Surrogate Marker)IBA 11/2006
1	Pamidronate (Aredia)FDA LinkGeneric 05/2006
1	Cholinergic ReceptorsIBA 11/2005
1	Neostigmine (Neostigmine Bromide)IBA 11/2005
1	Interleukin-1 (Interleukin 1)IBA 10/2004
1	factor AIBA 10/2004
1	Metalloproteases (Metalloproteinases)IBA 10/2001
1	3-Iodobenzylguanidine (Iobenguane)IBA 09/2001

Therapy/Procedure

4	Therapeutics 07/2016 - 02/2000
1	Neoadjuvant Therapy 03/2024
1	Art Therapy 07/2020
1	Reoperation 05/2018
1	Critical Care (Surgical Intensive Care) 06/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2012
1	Oral Administration 11/2011
1	Ileostomy 03/2011
1	Thymectomy 12/2006
1	Sternotomy 12/2006